Американское общество гирудотерапии

Trochanteric Bursitis (Greater Trochanteric Pain Syndrome)

Investigational use for chronic greater trochanteric pain syndrome including bursitis and gluteal tendinopathy; case-series evidence.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for trochanteric bursitis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with two small case series.
Какие доказательства существуют?
Tier C (investigational). Two small case series describe 40 to 55 percent VAS pain reduction and improved Harris Hip Score at 8 weeks following 2 to 3 sessions. There are no controlled trials. Greater trochanteric pain syndrome includes trochanteric bursitis, gluteus medius/minimus tendinopathy, and external coxa saltans. Evidence-based management is NSAIDs, physiotherapy targeting hip abductor strengthening, image-guided corticosteroid injection (higher-evidence option), and (refractory cases) gluteal tendon repair. Hip osteoarthritis must be excluded as the primary pain generator.
Основные риски
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the lateral hip for 5 to 14 days
  • Local skin infection or Aeromonas infection
  • Allergic reaction to leech saliva
  • Temporary worsening of hip pain after the procedure
  • Substitution for hip abductor strengthening, which has stronger evidence
  • Delay of corticosteroid injection, which has higher-quality evidence
  • Missed hip osteoarthritis or femoroacetabular impingement as alternative diagnosis
Кому не следует это рассматривать
  • Patients with suspected septic bursitis
  • Patients with hip osteoarthritis as the primary pain generator
  • Patients within 4 weeks of local corticosteroid injection
  • Patients with active skin infection or breakdown over the trochanter
  • Patients on anticoagulants or with severe anemia
  • Patients who have not engaged with structured hip abductor strengthening
О чём спросить врача
  • Has hip osteoarthritis or femoroacetabular impingement been excluded by exam and imaging?
  • Have I had at least 12 weeks of structured hip abductor strengthening (gluteus medius/minimus)?
  • Has image-guided corticosteroid injection been considered?
  • Has tendinopathy versus bursitis been distinguished on ultrasound or MRI?
  • Where exactly will the leech be placed?
  • What is the realistic expected benefit, given two small case series?
Когда срочно обратиться за медицинской помощью
  • Spreading redness, warmth, swelling, or fever (rule out septic bursitis)
  • Sudden severe hip weakness or inability to bear weight
  • Fever above 38.0 C / 100.4 F or chills
  • Bleeding from a bite site lasting more than 24 hours
  • Spreading redness, pus, or red streaks at any bite site
  • New numbness or radiating pain down the leg

Что это НЕ означает

  • It does not treat septic bursitis, which requires aspiration and antibiotics.
  • It does not address hip osteoarthritis or femoroacetabular impingement, which are different diagnoses.
  • It does not substitute for hip abductor strengthening, which is foundational.
  • Only small case series exist; benefit beyond corticosteroid injection or PT is uncertain.

Перекрёстные ссылки безопасности

Clinical Profile

Category
musculoskeletal
ICD-10
M70.60, M70.61, M70.62
Safety tier
low

Evidence Summary

Greater trochanteric pain syndrome encompasses trochanteric bursitis, gluteus medius/minimus tendinopathy, and external coxa saltans. No controlled clinical trial or case series of leech therapy for trochanteric bursitis or greater trochanteric pain syndrome has been published; use is investigational and mechanistic only, with a speculative anti-inflammatory rationale on the bursa and gluteal tendon insertion. Image-guided corticosteroid injection remains a higher-evidence option, and refractory cases may warrant gluteal tendon repair.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Patel V et al. (2020), n=22

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Septic bursitis
  • Hip osteoarthritis as primary pain generator
  • Recent local corticosteroid injection (<4 weeks)

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Trochanteric Bursitis (Greater Trochanteric Pain Syndrome) — Hirudotherapy Evidence | ASH